
According to data from Benzinga Pro, during Q4, Guardant Health's (NASDAQ:GH) reported sales totaled $108.11 million. Despite a 32.75% increase in earnings, the company posted a loss of $72.31 million. In Q3, Guardant Health brought in $94.78 million in sales but lost $107.53 million in earnings.